Amgen Inc. 2024 Q4 – Results – Earnings Call Presentation (NASDAQ:AMGN)

This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of…

Amgen: Growth Potential Met By High Debt Levels (NASDAQ:AMGN)

This article was written by Follow My analysis is focused on high-quality companies, that can outperform…

Amgen: Blockbusters, Emerging Therapies, And Investment Potential (NASDAQ:AMGN)

This article was written by Follow Originally a Biologist, M.Sc in Biomedicine, PhD in Bioengineerings, and…

Amgen: Strong Fundamentals But Expensive Valuation Justifies Hold (NASDAQ:AMGN)

This article was written by Follow Yavuz Akbay is quantitative analyst with over 5 years of…